Trending Now
Journal of Neuroscience Didn’t Find Data Manipulation Evidence in Research Article...
Cassava Sciences Inc. (NASDAQ: SAVA) has received communication from the Journal of Neurosciences that the research article published in July 2021 proposing a new...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Magenta Therapeutics Inc (NASDAQ:MGTA) And Beam Therapeutics Inc (NASDAQ:BEAM) Join Forces...
Magenta Therapeutics Inc (NASDAQ:MGTA) And Beam Therapeutics Inc (NASDAQ:BEAM) have announced their collaboration through which they will investigate MGTA-117 as a potential treatment for...
MAKE IT MODERN
LATEST REVIEWS
Catalyst Biosciences Inc. (NASDAQ: CBIO) Receives Rare Paediatric Diseases Designation for...
Catalyst Biosciences Inc. (NASDAQ: CBIO) has announced that the FDA has granted CB 4332 a Rare Paediatric Disease Designation (RPDD) for Complement Factor 1...
MAKE IT MODERN
PERFORMANCE TRAINING
Salesforce Inc (NYSE:CRM) moves higher on better than expected first quarter
Salesforce Inc (CRM) reported a better-than-expected first quarter on Tuesday after market close. The company hiked its full-year profit guidance that caused the...
Apple Inc (NASDAQ:AAPL) is heading towards 300 and here’s why
China easing triggered a rally in the market today. I think AAPL probably wants $300 so I might be a little early...
Innoviva Inc. Submits Proposal To Acquire All Outstanding Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX)...
Entasis Therapeutics Holdings Inc.’s (NASDAQ: ETTX) Board of Directors has received an interim, non-binding proposal from Innoviva Inc., its majority shareholder, to purchase all...
Inovio Pharmaceutical Inc. (NASDAQ:INO) Receives $71 Million Funding And Expands Executive Leadership To Advance...
Inovio Pharmaceutical Inc. (NASDAQ:INO) shares jumped almost 15% after the company announced that it had received $71 million from the Department of Defense to...
Ocugen Inc (NASDAQ:OCGN)’s partner Bharat Biotech rejected by Indian state
Ocugen Inc (NASDAQ:OCGN) is currently trading at $12.05 with a volume of over 52M shares.
Bharat Biotech's home...
MAKE IT MODERN
